Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12942884 | 0.82 | TSHR (0.46) | TSHRALDH1A1 | |
| SCHEMBL11808034 | 0.81 | TSHR (0.47) | TSHRALDH1A1 | |
| SCHEMBL6046773 | 0.81 | OPRM1 (0.39) | TSHRALDH1A1 | |
| SCHEMBL1142707 | 0.79 | TSHR (0.38) | TSHR | |
| SCHEMBL1142759 | 0.79 | TSHR (0.38) | TSHR | |
| SCHEMBL1142799 | 0.79 | TSHR (0.38) | TSHR | |
| SCHEMBL1142452 | 0.79 | TSHR (0.38) | TSHR | |
| SCHEMBL6435411 | 0.78 | TSHR (0.44) | TSHRALDH1A1 | |
| SCHEMBL667094 | 0.78 | TSHR (0.39) | TSHRALDH1A1 | |
| SCHEMBL28057379 | 0.78 | TSHR (0.36) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7645914-B2 | Method for the telomerization of non-cyclic olefins | EVONIK OXENO GMBH (DE) | 2010-01-12 | — | — | US | disclosed |
| US-20070213574-A1 | METHOD FOR THE TELOMERIZATION OF NON-CYCLIC OLEFINS | EVONIK DEGUSSA GMBH (DE) | 2007-09-13 | — | — | US | disclosed |
| US-4146738-A | ACTIVATED PALLADIUM TRIARYLPHOSPHINE CATALYST | CHEMISCHE WERKE HUELS, AKTIENGESELLSCHAFT (DE) | 1979-03-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070213574-A1 | METHOD FOR THE TELOMERIZATION OF NON-CYCLIC OLEFINS | TELO2, PCNA, TERT | TSHR 2970/4885ALDH1A1 3690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.